CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Clinical trial NCT03517176 · COMPLETED
Trial details
- NCT number
- NCT03517176
- Sponsor
- Lisata Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2020-06-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.